About Zhejiang Starry Pharmaceutical
Zhejiang Starry Pharmaceutical is a company based in Taizhou (China) founded in 1997.. Zhejiang Starry Pharmaceutical has completed 1 acquisition, including Imax Diagnostic. Zhejiang Starry Pharmaceutical operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Apicore, among others.
- Headquarter Taizhou, China
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$319.21 M (USD)7.05as on Dec 31, 2024
-
Net Profit
$-6.73 M (USD)-211as on Dec 31, 2024
-
EBITDA
$37.96 M (USD)-14.7as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Zhejiang Starry Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Zhejiang Starry Pharmaceutical
Zhejiang Starry Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Imax Diagnostic. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
APIs are manufactured and imaging services are provided.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Zhejiang Starry Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zhejiang Starry Pharmaceutical Comparisons
Competitors of Zhejiang Starry Pharmaceutical
Zhejiang Starry Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Apicore, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
APIs are manufactured and custom synthesis services are provided.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zhejiang Starry Pharmaceutical
Frequently Asked Questions about Zhejiang Starry Pharmaceutical
When was Zhejiang Starry Pharmaceutical founded?
Zhejiang Starry Pharmaceutical was founded in 1997.
Where is Zhejiang Starry Pharmaceutical located?
Zhejiang Starry Pharmaceutical is headquartered in Taizhou, China. It is registered at Taizhou, Jiangsu, China.
Who is the current CEO of Zhejiang Starry Pharmaceutical?
Hu Jinsheng is the current CEO of Zhejiang Starry Pharmaceutical.
What is the annual revenue of Zhejiang Starry Pharmaceutical?
Annual revenue of Zhejiang Starry Pharmaceutical is $319.21M as on Dec 31, 2024.
What does Zhejiang Starry Pharmaceutical do?
Zhejiang Starry Pharmaceutical was founded in 1997 and is based in Taizhou, China. Operations focus on the pharmaceutical sector, where active pharmaceutical ingredients (APIs) and intermediates are produced for X-CT non-ionic contrast media, MRI contrast media, and Fluoroquinolones. Products include Iohexol, Ioversol, Iopamidol, Iodixanol, Iopromide, Iomeprol, Gadobenate, and related compounds. Manufacturing occurs primarily for global supply chains in diagnostic imaging and antimicrobial applications.
Who are the top competitors of Zhejiang Starry Pharmaceutical?
Zhejiang Starry Pharmaceutical's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
How many acquisitions has Zhejiang Starry Pharmaceutical made?
Zhejiang Starry Pharmaceutical has made 1 acquisition, including Imax Diagnostic.